Alan Mendelsohn - Apr 15, 2022 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role
Chief Medical Officer
Signature
/s/ Joseph Lucchese, Power of Attorney
Stock symbol
TMBR
Transactions as of
Apr 15, 2022
Transactions value $
$0
Form type
4
Date filed
4/19/2022, 01:02 PM
Previous filing
Nov 24, 2021
Next filing
Apr 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +300K $0.00 300K Apr 15, 2022 Common Stock, par value $0.001 per share 300K $0.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options vest on April 15, 2023, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.